web analytics

Humira

$5,811.00 $4,900.00

 

Adalimumab belongs to the class of medications called biological response modifiers (“biologics”) or TNF blockers (tumor necrosis factor blocker). It is used to treat:

  • moderate-to-severe rheumatoid arthritis
  • severely active polyarticular juvenile idiopathic arthritis for children and adolescents from 4 to 17 years of age who have not responded adequately to other treatments
  • active psoriatic arthritis that has not responded to treatment with methotrexate
  • ankylosing spondylitis in adults who have not responded to other treatments
  • moderate-to-severe Crohn’s disease in adults who have not responded to other treatments
  • severely active Crohn’s disease in adolescents 13 to 17 years of age, weighing more than 40kg, who have not responded adequately to other treatments
  • moderate-to-severe psoriasis in adults
Translate »
Select your currency
USD United States (US) dollar
EUR Euro